Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a New Device to Measure Neuromuscular Disease Progression

NCT00606918 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00606918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00606918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a New Device to Measure Neuromuscular Disease Progression
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 2008
Completion date
September 30, 2010
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis & other neuromuscular disorders